
Alphabet (GOOGL) is a high-conviction long-term investment, as its foundational AI models position it to lead future markets in robotics, drug discovery, and AI-powered software. For a specific catalyst, monitor Eli Lilly (LLY) and Novartis (NVS), as their AI drug discovery partnership with Google is expected to produce preclinical candidates in 2025. Conversely, the development of generative world models like Google's Genie presents a significant long-term risk to the business model of game engine company Unity (U). The robotics sector is approaching a major inflection point, making GOOGL's strategy to build the industry's core operating system a prime way to gain exposure. Overall, the key takeaway is to be long GOOGL as a foundational AI play while being cautious on companies like U that face direct disruption.

By All-In Podcast, LLC
Industry veterans, degenerate gamblers & besties Chamath Palihapitiya, Jason Calacanis, David Sacks & David Friedberg cover all things economic, tech, political, social & poker.